Shuanghe Peng

523 total citations
23 papers, 379 citations indexed

About

Shuanghe Peng is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Shuanghe Peng has authored 23 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Shuanghe Peng's work include Renal cell carcinoma treatment (9 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Renal and related cancers (5 papers). Shuanghe Peng is often cited by papers focused on Renal cell carcinoma treatment (9 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Renal and related cancers (5 papers). Shuanghe Peng collaborates with scholars based in China and United States. Shuanghe Peng's co-authors include Zhun Wang, Kan Gong, Xianghui Ning, Jiangyi Wang, Ning Jiang, Hui Xie, Yuanjie Niu, Zhiqun Shang, Aixiang Wang and Qiliang Cai and has published in prestigious journals such as Cancer Research, Clinica Chimica Acta and Urology.

In The Last Decade

Shuanghe Peng

23 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuanghe Peng China 13 197 171 168 150 65 23 379
Alessandra Modena Italy 11 183 0.9× 114 0.7× 148 0.9× 147 1.0× 59 0.9× 29 368
Gui-Ming Zhang China 12 157 0.8× 118 0.7× 132 0.8× 144 1.0× 77 1.2× 21 361
Lisly Chéry United States 8 227 1.2× 219 1.3× 261 1.6× 117 0.8× 58 0.9× 22 478
Megan E. Lampron United States 6 286 1.5× 152 0.9× 181 1.1× 217 1.4× 100 1.5× 8 448
Hideki Ushiku Japan 15 191 1.0× 106 0.6× 228 1.4× 159 1.1× 151 2.3× 39 478
Meike Adam Germany 11 292 1.5× 127 0.7× 217 1.3× 72 0.5× 50 0.8× 22 438
Eduardo Caetano Albino da Silva Brazil 11 122 0.6× 102 0.6× 140 0.8× 123 0.8× 104 1.6× 28 350
Renzo G. DiNatale United States 13 306 1.6× 126 0.7× 223 1.3× 118 0.8× 107 1.6× 33 417
Zhi‐Bin Ke China 14 306 1.6× 213 1.2× 260 1.5× 83 0.6× 90 1.4× 61 574
Youcai Zhao China 10 82 0.4× 158 0.9× 176 1.0× 118 0.8× 45 0.7× 25 348

Countries citing papers authored by Shuanghe Peng

Since Specialization
Citations

This map shows the geographic impact of Shuanghe Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuanghe Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuanghe Peng more than expected).

Fields of papers citing papers by Shuanghe Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuanghe Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuanghe Peng. The network helps show where Shuanghe Peng may publish in the future.

Co-authorship network of co-authors of Shuanghe Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Shuanghe Peng. A scholar is included among the top collaborators of Shuanghe Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuanghe Peng. Shuanghe Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Hui, Yang Zhao, Zhun Wang, et al.. (2023). YAP is required for prostate development, regeneration, and prostate stem cell function. Cell Death Discovery. 9(1). 339–339. 3 indexed citations
2.
3.
Wang, Zhun, et al.. (2022). Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer. Frontiers in Genetics. 13. 778850–778850. 10 indexed citations
4.
Tang, Huiqin, et al.. (2022). Economical and Efficient Protocol for Isolating and Culturing Bone Marrow-derived Dendritic Cells from Mice. Journal of Visualized Experiments. 3 indexed citations
5.
Xie, Hui, Zheng Zhang, Zhun Wang, et al.. (2021). Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines. 9(7). 786–786. 13 indexed citations
6.
Peng, Xiang, Jinchao Chen, Shuanghe Peng, et al.. (2019). Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients. Journal of Medical Genetics. 56(6). 380–387. 10 indexed citations
7.
8.
Wang, Zhun, Shuanghe Peng, Hui Xie, et al.. (2018). Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals. Clinical and Experimental Medicine. 18(2). 165–175. 42 indexed citations
9.
Wang, Zhun, Shuanghe Peng, Hui Xie, et al.. (2018). Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis. Cancer Management and Research. Volume 10. 3599–3610. 11 indexed citations
10.
Wang, Zhun, Shuanghe Peng, Aixiang Wang, et al.. (2018). Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma. Clinica Chimica Acta. 480. 166–172. 37 indexed citations
11.
Liu, Shengjie, Jiangyi Wang, Shuanghe Peng, et al.. (2018). Genotype and phenotype correlation in von Hippel–Lindau disease based on alteration of the HIF-α binding site in VHL protein. Genetics in Medicine. 20(10). 1266–1273. 31 indexed citations
12.
Wang, Zhun, et al.. (2018). Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma. Clinica Chimica Acta. 486. 9–17. 20 indexed citations
13.
Wang, Jiangyi, Shuanghe Peng, Xianghui Ning, et al.. (2017). Shorter telomere length increases age‐related tumor risks in von Hippel‐Lindau disease patients. Cancer Medicine. 6(9). 2131–2141. 15 indexed citations
14.
Wang, Zhun, Shuanghe Peng, Aixiang Wang, et al.. (2017). C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis. Clinica Chimica Acta. 475. 178–187. 12 indexed citations
15.
Li, Teng, Jinchao Chen, Yuan Jiang, et al.. (2016). Multilocular Cystic Renal Cell Neoplasm of Low Malignant Potential: A Series of 76 Cases. Clinical Genitourinary Cancer. 14(6). e553–e557. 29 indexed citations
16.
Ning, Xianghui, Li Teng, Yanqing Gong, et al.. (2016). Association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinoma. Oncology Letters. 11(6). 4095–4098. 18 indexed citations
17.
18.
Chen, Jinchao, Min Yang, Teng Li, et al.. (2016). Renal Arterial Pseudoaneurysm and Renal Arteriovenous Fistula Following Partial Nephrectomy. Urologia Internationalis. 100(3). 368–374. 9 indexed citations
19.
Wang, Xi, Ning Zhang, Xianghui Ning, et al.. (2014). Higher Prevalence of Novel Mutations in VHL Gene in Chinese Von Hippel-Lindau Disease Patients. Urology. 83(3). 675.e1–675.e6. 9 indexed citations
20.
Ning, Xianghui, Ning Zhang, Pengjie Wu, et al.. (2014). Telomere Shortening Is Associated with Genetic Anticipation in Chinese Von Hippel–Lindau Disease Families. Cancer Research. 74(14). 3802–3809. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Modena Breakdown of academic impact, for papers by Gui-Ming Zhang Breakdown of academic impact, for papers by Lisly Chéry Breakdown of academic impact, for papers by Megan E. Lampron Breakdown of academic impact, for papers by Hideki Ushiku Breakdown of academic impact, for papers by Meike Adam Breakdown of academic impact, for papers by Eduardo Caetano Albino da Silva Breakdown of academic impact, for papers by Renzo G. DiNatale Breakdown of academic impact, for papers by Zhi‐Bin Ke Breakdown of academic impact, for papers by Youcai Zhao
Rankless by CCL
2026